Title: Capturing of the free cysteine residue in the ligand-binding site by affinity labeling of the ORL1 nociceptin receptor.
Journal: Bioorganic & medicinal chemistry 20111215
Title: In vitro studies of the activity of newly sinthesized nociceptin / orphanin FQ receptor ligand analogues.
Journal: Protein and peptide letters 20100501
Title: Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist.
Journal: Bioorganic & medicinal chemistry 20080301
Title: Opioid receptor-like 1 (ORL1) receptor binding and the biological properties of Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH2 and its analogs.
Journal: Journal of peptide science : an official publication of the European Peptide Society 20071001
Title: Receptor binding properties and antinociceptive effects of chimeric peptides consisting of a micro-opioid receptor agonist and an ORL1 receptor antagonist.
Journal: Biological & pharmaceutical bulletin 20070701
Title: Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
Journal: British journal of pharmacology 20021201
Title: Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.
Journal: British journal of pharmacology 20000901
Title: H Berger, et al. Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br J Pharmacol. 1999 Feb;126(3):555-8.
Title: H Berger, et al. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.Peptides. 2000 Jul;21(7):1131-9.
Title: C T Dooley, et al. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J Pharmacol Exp Ther. 1997 Nov;283(2):735-41.
